Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New balance training could cut fall risk for seniors with brain circulation issues

NCT ID NCT07358338

First seen Jan 25, 2026 · Last updated Jun 23, 2026 · Updated 24 times

Summary

This study tests whether two biofeedback devices—a balance platform (Huber) and a smart treadmill (C-Mill)—can improve balance and reduce fall risk in 120 older adults (65+) with chronic cerebral ischemia. Participants will do 8 sessions of training, and researchers will compare their fall risk, balance, and cognitive function to a control group doing standard exercises. The goal is to see if these high-tech tools are better than regular therapy for preventing falls.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAIT DISORDERS, NEUROLOGIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • MEDSI Clinic

    Moscow, 143442, Russia

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Biofeedback training devices (Huber stabilizer and C-Mill treadmill)

What this could lead to

If successful, this could provide a new, non-drug way to improve balance and reduce falls in older adults with chronic brain circulation problems.

What could go wrong

This is a small, early-stage study with 120 participants, so results may not apply to everyone. The devices are not widely available, and benefits may be modest.

Conditions

The condition(s) this trial relates to.

brain ischemia cerebrovascular disorder Gait Disorders, Neurologic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.